SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Oxford GlycoSciences Plc
An SI Board Since January 2000
Posts SubjectMarks Bans
469 13 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
OGS Announced Proteomics Deal with Merck

ogs.com

martin
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
469re. the current fear of a flu pandemic, we've discussed at least two agents scaram(o)uche-10/7/2005
468Actelion takes control of Celltech's Zavesca drug ZURICH, June 16 (Reuters)nigel bates-6/16/2004
467FDA finally give Zavesca the nod - Message 19174121nigel bates-8/3/2003
466Well, yes. OTOH, you have to give them credit for succesful grand larceny. Innigel bates-5/22/2003
4651. Duh! 2. Grrrrrrrrrrrrrrr................scaram(o)uche-5/22/2003
464From Celltech agm statement: "...Celltech's acquisition of OGS, announnigel bates-5/22/2003
463Richard, a follow up post to your post # 253 "more deep stuff from Progen..Henrik-5/7/2003
462Article on target validation at three companies, including OGS: dddmag.com Chetuck-4/28/2003
461All I could find - <i>If you have any questions about procedures for accenigel bates-4/24/2003
460No - I'm afraid I sold in the market last week. Just got back from a couplenigel bates-4/23/2003
459Anyone have an indication when the t/o will close and we get cashed out? Today keokalani'nui-4/22/2003
458Ditto, almost word for word (if you substitute £1.38 for $2.30).nigel bates-4/15/2003
457I bought some during the bail. I remember that OGSI was trading in the 2.2-2.3 rSpekulatius-4/14/2003
456Back in for a day, but going for Utah tomorrow morning . . . >>LONDON tuck-4/14/2003
455Not the action of a group which has just overpaid for an acquisition... <i&gnigel bates-4/14/2003
454I hate the anti-heparanase project. Have from the second I heard about the dealscaram(o)uche-4/13/2003
453According to the Sundays, Celltech have nearly 50% secured. They will retain bionigel bates-4/13/2003
452Abject surrender. <i>I'm an absolute idiot," says David Ebsworthnigel bates-4/11/2003
451From FT Investor. "Dig into their own pockets" - unthinkable... <nigel bates-4/11/2003
450The Evans/Goodman statement - <pre>Christopher Evans & Alan Goodman nigel bates-4/11/2003
449Possibly the MEDX deal is too big of a potential cash liability for any more oppnigel bates-4/11/2003
448<b>Everybody</b> wimps out - <pre> Oxford GlycoSciences Plcnigel bates-4/11/2003
447By Mark Potter LONDON, April 9 (Reuters) - Britain's Celltech Group Plc stoonigel bates-4/9/2003
446UK Takeover Panel OKs Oxford Glycosciences Results Date Wednesday April 9, 5:37 nigel bates-4/9/2003
445Glycomics, parking momentapharma.com <i>Alan L. Crane MBA Chairman and Cnigel bates-4/7/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News